» Articles » PMID: 15107968

Serotonin 5-HT2A Receptors in the CA1 Field of the Hippocampus Mediate Head Movements in the Rabbit

Overview
Specialty Pharmacology
Date 2004 Apr 27
PMID 15107968
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Motor movements (head bobs) in the rabbit have been shown to be elicited by LSD-like hallucinogenic drugs through actions at central serotonin 5-HT(2A) receptors, though their central locus remains unknown. Serotonergic innervation of the hippocampus has been suggested to play an important role in motor programming including movements of the head.

Objectives: We examined whether intrahippocampal injections of a 5-HT(2A) receptor agonist would elicit head bobs and whether elicitation of head bobs would be modified by increases in hippocampal 5-HT(2A) receptor density.

Methods: Animals received bilateral injections of DOI or its vehicle into the dorsal hippocampus either before or after chronic administration of MDL 11,939 or its vehicle. The number of head bobs was counted continuously for 60 min and reported in blocks of 10 min and this was compared with the density of 5-HT(2A) receptors in dorsal hippocampus.

Results: Infusion of DOI into the CA1 region of the dorsal hippocampus elicited head bobs that were blocked by prior intrahippocampal injection of the 5-HT(2A) receptor antagonist ketanserin. Receptor autoradiography revealed that chronic administration of MDL 11,939 produced a 2.5-fold up-regulation of 5-HT(2A) receptors in the CA1 field and dentate gyrus of the hippocampus. This 5-HT(2A) receptor up-regulation was associated with a nearly 2-fold increase in head bobs elicited by infusion of DOI into the CA1 field.

Conclusions: These results indicate that 5-HT(2A) receptors located in the CA1 field of the hippocampus mediate a motor movement, head bobs, and that this mediation is functionally related to receptor density.

Citing Articles

LSD degrades hippocampal spatial representations and suppresses hippocampal-visual cortical interactions.

Domenico C, Haggerty D, Mou X, Ji D Cell Rep. 2021; 36(11):109714.

PMID: 34525364 PMC: 9798728. DOI: 10.1016/j.celrep.2021.109714.


Psychedelics.

Nichols D Pharmacol Rev. 2016; 68(2):264-355.

PMID: 26841800 PMC: 4813425. DOI: 10.1124/pr.115.011478.


Hippocampal serotonin depletion unmasks differences in the hyperlocomotor effects of phencyclidine and MK-801: quantitative versus qualitative analyses.

Adams W, Halberstadt A, van den Buuse M Front Pharmacol. 2013; 4:109.

PMID: 24009584 PMC: 3756227. DOI: 10.3389/fphar.2013.00109.


Intrahippocampal LSD accelerates learning and desensitizes the 5-HT(2A) receptor in the rabbit, Romano et al.

Romano A, Quinn J, Li L, Dave K, Schindler E, Aloyo V Psychopharmacology (Berl). 2010; 212(3):441-8.

PMID: 20827462 DOI: 10.1007/s00213-010-2004-7.


Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice.

Klein A, Santini M, Aznar S, Knudsen G, Rios M Neuroscience. 2010; 169(3):1007-16.

PMID: 20576498 PMC: 2914121. DOI: 10.1016/j.neuroscience.2010.05.054.


References
1.
Williams G, Rao S, Goldman-Rakic P . The physiological role of 5-HT2A receptors in working memory. J Neurosci. 2002; 22(7):2843-54. PMC: 6758292. DOI: 20026203. View

2.
Wang R, Arvanov V . M100907, a highly selective 5-HT2A receptor antagonist and a potential atypical antipsychotic drug, facilitates induction of long-term potentiation in area CA1 of the rat hippocampal slice. Brain Res. 1998; 779(1-2):309-13. DOI: 10.1016/s0006-8993(97)01174-8. View

3.
Sainsbury R . Hippocampal theta: a sensory-inhibition theory of function. Neurosci Biobehav Rev. 1998; 22(2):237-41. DOI: 10.1016/s0149-7634(97)00011-0. View

4.
Dave K, Harvey J, Aloyo V . A novel behavioral model that discriminates between 5-HT2A and 5-HT2C receptor activation. Pharmacol Biochem Behav. 2002; 72(1-2):371-8. DOI: 10.1016/s0091-3057(01)00767-5. View

5.
Nagayama H, Lu J . Circadian rhythm in the responsiveness of central 5-HT2A receptor to DOI in rats. Psychopharmacology (Berl). 1996; 127(2):113-6. DOI: 10.1007/BF02805983. View